- Home
- ADVB vs CLDI Comparison
ADVB vs CLDI Comparison
Compare ADVB & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- CLDI
- Stock Information
- Founded
- ADVB 2014
- CLDI 2014
- Country
- ADVB United States
- CLDI United States
- Employees
- ADVB N/A
- CLDI N/A
- Industry
- ADVB Medical Specialities
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ADVB Health Care
- CLDI Health Care
- Exchange
- ADVB Nasdaq
- CLDI Nasdaq
- Market Cap
- ADVB 9.7M
- CLDI 9.9M
- IPO Year
- ADVB 2025
- CLDI N/A
- Fundamental
- Price
- ADVB $0.42
- CLDI $1.48
- Analyst Decision
- ADVB
- CLDI
- Analyst Count
- ADVB 0
- CLDI 0
- Target Price
- ADVB N/A
- CLDI N/A
- AVG Volume (30 Days)
- ADVB 1.7M
- CLDI 232.3K
- Earning Date
- ADVB 11-19-2025
- CLDI 11-13-2025
- Dividend Yield
- ADVB N/A
- CLDI N/A
- EPS Growth
- ADVB N/A
- CLDI N/A
- EPS
- ADVB N/A
- CLDI N/A
- Revenue
- ADVB N/A
- CLDI N/A
- Revenue This Year
- ADVB N/A
- CLDI N/A
- Revenue Next Year
- ADVB N/A
- CLDI N/A
- P/E Ratio
- ADVB N/A
- CLDI N/A
- Revenue Growth
- ADVB N/A
- CLDI N/A
- 52 Week Low
- ADVB $0.34
- CLDI $1.10
- 52 Week High
- ADVB $4.10
- CLDI $27.63
- Technical
- Relative Strength Index (RSI)
- ADVB 47.63
- CLDI 50.54
- Support Level
- ADVB $0.36
- CLDI $1.29
- Resistance Level
- ADVB $0.49
- CLDI $1.56
- Average True Range (ATR)
- ADVB 0.04
- CLDI 0.13
- MACD
- ADVB -0.00
- CLDI 0.00
- Stochastic Oscillator
- ADVB 44.36
- CLDI 86.96
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.